The Systemic Effects of Endometriosis

Myles H. Alderman III; Nicole Yoder; Hugh S. Taylor

doi:10.1055/s-0037-1603582

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2017; 35(03): 263-270
DOI: 10.1055/s-0037-1603582

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Systemic Effects of Endometriosis

Authors

Myles H. Alderman III^*

¹Department of Obstetrics and Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
Nicole Yoder^*

¹Department of Obstetrics and Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
Hugh S. Taylor

¹Department of Obstetrics and Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut

Abstract

Endometriosis is a condition defined by the presence of endometrial glands and stroma in ectopic locations. While the most commonly seen symptoms of the disease are pelvic pain, dysmenorrhea, and infertility, endometriosis has also systemic effects in multiple organ systems. Here, we review literature describing closely associated comorbidities including cardiovascular disease, cancers, autoimmune disease, psychiatric conditions, and metabolism/body weight. We examine the pathophysiology and hypothesized mechanism by which endometriosis may lead to these systemic effects; mechanisms include cytokine and micro-RNA production as well as stem cell migration and dissemination. The broad systemic effects of endometriosis as well as correlated comorbidities are often overlooked in the treatment of patients with endometriosis. Increased awareness may lead to more effective treatment and prevention.

Keywords

endometriosis - pain - inflammation - miRNA - stem cells - CXCL12

Volltext

Referenzen

References
1 Cramer DW, Missmer SA. The epidemiology of endometriosis. Ann N Y Acad Sci 2002; 955 (01) 11-22 , discussion 34–36, 396–406
2 De Graaff AA, D'Hooghe TM, Dunselman GA, Dirksen CD, Hummelshoj L, Simoens S. ; WERF EndoCost Consortium. The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey. Hum Reprod 2013; 28 (10) 2677-2685
3 Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927; 3 (02) 93-110 , 43
4 Goetz LG, Mamillapalli R, Taylor HS. Low body mass index in endometriosis is promoted by hepatic metabolic gene dysregulation in mice. Biol Reprod 2016; 95 (06) 115
5 Kvaskoff M, Mu F, Terry KL. , et al. Endometriosis: a high-risk population for major chronic diseases?. Hum Reprod Update 2015; 21 (04) 500-516
6 Gemmill JA, Stratton P, Cleary SD, Ballweg ML, Sinaii N. Cancers, infections, and endocrine diseases in women with endometriosis. Fertil Steril 2010; 94 (05) 1627-1631
7 Teng SW, Horng HC, Ho CH, Yen MS, Chao HT, Wang PH. ; Taiwan Association of Gynecology Systematic Review Group. Women with endometriosis have higher comorbidities: analysis of domestic data in Taiwan. J Chin Med Assoc 2016; 79 (11) 577-582
8 Cosar E, Mamillapalli R, Ersoy GS, Cho S, Seifer B, Taylor HS. Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis. Fertil Steril 2016; 106 (02) 402-409
9 Monsanto SP, Edwards AK, Zhou J. , et al. Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients. Fertil Steril 2016; 105 (04) 968-977.e5
10 Gazvani R, Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 2002; 123 (02) 217-226
11 Sakr S, Naqvi H, Komm B, Taylor HS. Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment. Endocrinology 2014; 155 (04) 1489-1497
12 Naqvi H, Mamillapalli R, Krikun G, Taylor HS. Endometriosis located proximal to or remote from the uterus differentially affects uterine gene expression. Reprod Sci 2016; 23 (02) 186-191
13 Wilson PW. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. Am J Med 2008; 121 (10) (Suppl. 01) S15-S20
14 Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J. Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol 2011; 27 (02) 174-182
15 Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D. Is endometriosis associated with systemic subclinical inflammation?. Gynecol Obstet Invest 2006; 62 (03) 139-147
16 Nothnick W, Alali Z. Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment. F1000 Res 2016; 5: F1000 Faculty Rev-186
17 Mu F, Rich-Edwards J, Rimm EB, Spiegelman D, Missmer SA. Endometriosis and risk of coronary heart disease. Circ Cardiovasc Qual Outcomes 2016; 9 (03) 257-264
18 Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18 (06) 655-673
19 Gupta S, Agarwal A, Krajcir N, Alvarez JG. Role of oxidative stress in endometriosis. Reprod Biomed Online 2006; 13 (01) 126-134
20 Van Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril 2002; 77 (05) 861-870
21 Melo AS, Rosa-e-Silva JC, Rosa-e-Silva Ade S, Poli-Neto OB, Ferriani RA, Vieira CS. Unfavorable lipid profile in women with endometriosis. Fertil Steril 2010; 93 (07) 2433-2436
22 Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997; 176 (03) 572-579
23 Melin A, Sparén P, Persson I, Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006; 21 (05) 1237-1242
24 Ness RB. Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol 2003; 189 (01) 280-294
25 Munksgaard PS, Blaakaer J. The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data. Gynecol Oncol 2011; 123 (01) 157-163
26 Farland LV, Tamimi RM, Eliassen AH. , et al. Laparoscopically confirmed endometriosis and breast cancer in the Nurses' Health Study II. Obstet Gynecol 2016; 128 (05) 1025-1031
27 Mogensen JB, Kjær SK, Mellemkjær L, Jensen A. Endometriosis and risks for ovarian, endometrial and breast cancers: a nationwide cohort study. Gynecol Oncol 2016; 143 (01) 87-92
28 Pontikaki A, Sifakis S, Spandidos DA. Endometriosis and breast cancer: a survey of the epidemiological studies. Oncol Lett 2016; 11 (01) 23-30
29 Melin A, Sparén P, Bergqvist A. The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 2007; 22 (11) 3021-3026
30 Borgfeldt C, Andolf E. Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand 2004; 83 (04) 395-400
31 Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA. Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study. Cancer 2002; 94 (05) 1612-1618
32 Kvaskoff M, Mesrine S, Fournier A, Boutron-Ruault MC, Clavel-Chapelon F. Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women. Arch Intern Med 2007; 167 (19) 2061-2065
33 Kvaskoff M, Han J, Qureshi AA, Missmer SA. Pigmentary traits, family history of melanoma and the risk of endometriosis: a cohort study of US women. Int J Epidemiol 2014; 43 (01) 255-263
34 Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002; 17 (10) 2715-2724
35 Nielsen NM, Jørgensen KT, Pedersen BV, Rostgaard K, Frisch M. The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome. Hum Reprod 2011; 26 (06) 1555-1559
36 Aguiar FM, Melo SB, Galvão LC, Rosa-e-Silva JC, dos Reis RM, Ferriani RA. Serological testing for celiac disease in women with endometriosis. A pilot study. Clin Exp Obstet Gynecol 2009; 36 (01) 23-25
37 Jess T, Frisch M, Jørgensen KT, Pedersen BV, Nielsen NM. Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study. Gut 2012; 61 (09) 1279-1283
38 Petta CA, Arruda MS, Zantut-Wittmann DE, Benetti-Pinto CL. Thyroid autoimmunity and thyroid dysfunction in women with endometriosis. Hum Reprod 2007; 22 (10) 2693-2697
39 Yuk J-S, Ji H-Y, Lee JH, Park WI. Graves' disease is associated with endometriosis: 3-year population-based study. J Minim Invasive Gynecol 2015; 22 (6S): S29
40 Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?. Trends Mol Med 2003; 9 (05) 223-228
41 Eisenberg VH, Zolti M, Soriano D. Is there an association between autoimmunity and endometriosis?. Autoimmun Rev 2012; 11 (11) 806-814
42 Nichols TR, Lamb K, Arkins JA. The association of atopic diseases with endometriosis. Ann Allergy 1987; 59 (05) 360-363
43 Matalliotakis I, Cakmak H, Matalliotakis M, Kappou D, Arici A. High rate of allergies among women with endometriosis. J Obstet Gynaecol 2012; 32 (03) 291-293
44 Bungum HF, Vestergaard C, Knudsen UB. Endometriosis and type 1 allergies/immediate type hypersensitivity: a systematic review. Eur J Obstet Gynecol Reprod Biol 2014; 179: 209-215
45 Caserta D, Mallozzi M, Pulcinelli FM, Mossa B, Moscarini M. Endometriosis allergic or autoimmune disease: pathogenetic aspects--a case control study. Clin Exp Obstet Gynecol 2016; 43 (03) 354-357
46 Chen LC, Hsu JW, Huang KL. , et al. Risk of developing major depression and anxiety disorders among women with endometriosis: a longitudinal follow-up study. J Affect Disord 2016; 190: 282-285
47 Sepulcri RP, do Amaral VF. Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol 2009; 142 (01) 53-56
48 Lorençatto C, Petta CA, Navarro MJ, Bahamondes L, Matos A. Depression in women with endometriosis with and without chronic pelvic pain. Acta Obstet Gynecol Scand 2006; 85 (01) 88-92
49 Pope CJ, Sharma V, Sharma S, Mazmanian D. A systematic review of the association between psychiatric disturbances and endometriosis. J Obstet Gynaecol Can 2015; 37 (11) 1006-1015
50 Yi KW, Shin JH, Park MS, Kim T, Kim SH, Hur JY. Association of body mass index with severity of endometriosis in Korean women. Int J Gynaecol Obstet 2009; 105 (01) 39-42
51 Hediger ML, Hartnett HJ, Louis GM. Association of endometriosis with body size and figure. Fertil Steril 2005; 84 (05) 1366-1374
52 Ferrero S, Anserini P, Remorgida V, Ragni N. Body mass index in endometriosis. Eur J Obstet Gynecol Reprod Biol 2005; 121 (01) 94-98
53 Lafay Pillet MC, Schneider A, Borghese B. , et al. Deep infiltrating endometriosis is associated with markedly lower body mass index: a 476 case-control study. Hum Reprod 2012; 27 (01) 265-272
54 Vitonis AF, Baer HJ, Hankinson SE, Laufer MR, Missmer SA. A prospective study of body size during childhood and early adulthood and the incidence of endometriosis. Hum Reprod 2010; 25 (05) 1325-1334
55 McCann SE, Freudenheim JL, Darrow SL, Batt RE, Zielezny MA. Endometriosis and body fat distribution. Obstet Gynecol 1993; 82 (4, Pt 1): 545-549
56 Shah DK, Correia KF, Vitonis AF, Missmer SA. Body size and endometriosis: results from 20 years of follow-up within the Nurses' Health Study II prospective cohort. Hum Reprod 2013; 28 (07) 1783-1792
57 Pluchino N, Taylor HS. Endometriosis and stem cell trafficking. Reprod Sci 2016; 23 (12) 1616-1619
58 Punnonen J, Teisala K, Ranta H, Bennett B, Punnonen R. Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis. Am J Obstet Gynecol 1996; 174 (05) 1522-1526
59 Harada T, Yoshioka H, Yoshida S. , et al. Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis. Am J Obstet Gynecol 1997; 176 (03) 593-597
60 Sikora J, Mielczarek-Palacz A, Kondera-Anasz Z. Imbalance in cytokines from interleukin-1 family - role in pathogenesis of endometriosis. Am J Reprod Immunol 2012; 68 (02) 138-145
61 Eisermann J, Gast MJ, Pineda J, Odem RR, Collins JL. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 1988; 50 (04) 573-579
62 Ahn SH, Edwards AK, Singh SS, Young SL, Lessey BA, Tayade C. IL-17A contributes to the pathogenesis of endometriosis by triggering proinflammatory cytokines and angiogenic growth factors. J Immunol 2015; 195 (06) 2591-2600
63 Kennedy S, Bergqvist A, Chapron C. , et al; ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005; 20 (10) 2698-2704
64 Fagervold B, Jenssen M, Hummelshoj L, Moen MH. Life after a diagnosis with endometriosis - a 15 years follow-up study. Acta Obstet Gynecol Scand 2009; 88 (08) 914-919
65 Fourquet J, Gao X, Zavala D. , et al. Patients' report on how endometriosis affects health, work, and daily life. Fertil Steril 2010; 93 (07) 2424-2428
66 Bruner-Tran KL, Herington JL, Duleba AJ, Taylor HS, Osteen KG. Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology. Minerva Ginecol 2013; 65 (02) 199-213
67 Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 2014; 10 (05) 261-275
68 Barcena de Arellano ML, Arnold J, Vercellino F, Chiantera V, Schneider A, Mechsner S. Overexpression of nerve growth factor in peritoneal fluid from women with endometriosis may promote neurite outgrowth in endometriotic lesions. Fertil Steril 2011; 95 (03) 1123-1126
69 McKinnon BD, Bertschi D, Bersinger NA, Mueller MD. Inflammation and nerve fiber interaction in endometriotic pain. Trends Endocrinol Metab 2015; 26 (01) 1-10
70 Barcena de Arellano ML, Arnold J, Lang H. , et al. Evidence of neurotrophic events due to peritoneal endometriotic lesions. Cytokine 2013; 62 (02) 253-261
71 Quiñones M, Urrutia R, Torres-Reverón A, Vincent K, Flores I. Anxiety, coping skills and hypothalamus-pituitary-adrenal (HPA) axis in patients with endometriosis. J Reprod Biol Health 2015; 3 (01) 2
72 Petrelluzzi KF, Garcia MC, Petta CA, Grassi-Kassisse DM, Spadari-Bratfisch RC. Salivary cortisol concentrations, stress and quality of life in women with endometriosis and chronic pelvic pain. Stress 2008; 11 (05) 390-397
73 Brawn J, Morotti M, Zondervan KT, Becker CM, Vincent K. Central changes associated with chronic pelvic pain and endometriosis. Hum Reprod Update 2014; 20 (05) 737-747
74 Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009; 11 (03) 228-234
75 Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116 (02) 281-297
76 Ohlsson Teague EM, Van der Hoek KH, Van der Hoek MB. , et al. MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol 2009; 23 (02) 265-275
77 Cho S, Mutlu L, Grechukhina O, Taylor HS. Circulating microRNAs as potential biomarkers for endometriosis. Fertil Steril 2015; 103 (05) 1252-60.e1
78 Seifer BJ, Su D, Taylor HS. Circulating miRNAs in murine experimental endometriosis. Reprod Sci 2017; 24 (03) 376-381
79 Teague EM, Print CG, Hull ML. The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update 2010; 16 (02) 142-165
80 Ramón LA, Braza-Boïls A, Gilabert-Estellés J. , et al. microRNAs expression in endometriosis and their relation to angiogenic factors. Hum Reprod 2011; 26 (05) 1082-1090
81 Braza-Boïls A, Salloum-Asfar S, Marí-Alexandre J. , et al. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis. Hum Reprod 2015; 30 (10) 2292-2302
82 Braza-Boïls A, Marí-Alexandre J, Gilabert J. , et al. MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors. Hum Reprod 2014; 29 (05) 978-988
83 Braza-Boïls A, Gilabert-Estellés J, Ramón LA. , et al. Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis. PLoS One 2013; 8 (04) e62370
84 Hawkins SM, Creighton CJ, Han DY. , et al. Functional microRNA involved in endometriosis. Mol Endocrinol 2011; 25 (05) 821-832
85 Burney RO, Hamilton AE, Aghajanova L. , et al. MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis. Mol Hum Reprod 2009; 15 (10) 625-631
86 Chen S, Yang L, Jie Q. , et al. MicroRNA‑125b suppresses the proliferation and osteogenic differentiation of human bone marrow‑derived mesenchymal stem cells. Mol Med Rep 2014; 9 (05) 1820-1826
87 Wang H, Tan G, Dong L. , et al. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One 2012; 7 (04) e34210
88 Sasson IE, Taylor HS. Stem cells and the pathogenesis of endometriosis. Ann N Y Acad Sci 2008; 1127 (01) 106-115
89 Cassina PC, Hauser M, Kacl G, Imthurn B, Schröder S, Weder W. Catamenial hemoptysis. Diagnosis with MRI. Chest 1997; 111 (05) 1447-1450
90 Van Schil PE, Vercauteren SR, Vermeire PA, Nackaerts YH, Van Marck EA. Catamenial pneumothorax caused by thoracic endometriosis. Ann Thorac Surg 1996; 62 (02) 585-586
91 Gruenwald P. Origin of endometriosis from the mesenchyme of the celomic walls. Am J Obstet Gynecol 1942; 44 (03) 470-474
92 Du H, Taylor HS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells 2007; 25 (08) 2082-2086
93 Figueira PG, Abrão MS, Krikun G, Taylor HS. Stem cells in endometrium and their role in the pathogenesis of endometriosis. Ann N Y Acad Sci 2011; 1221 (01) 10-17
94 Wang X, Mamillapalli R, Mutlu L, Du H, Taylor HS. Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cells is mediated by estradiol regulated CXCL12 and CXCR4 expression. Stem Cell Res (Amst) 2015; 15 (01) 14-22
95 Taylor HS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 2004; 292 (01) 81-85
96 Moridi I, Mamillapalli R, Cosar E, Ersoy GS, Taylor HS. Bone marrow stem cell chemotactic activity is induced by elevated CXCl12 in endometriosis. Reprod Sci 2017; 24 (04) 526-533
97 Liu Y, Gao S, Wang Z, Yang Y, Huo H, Tian X. Effect of stromal cell-derived factor-1 on myocardial apoptosis and cardiac function recovery in rats with acute myocardial infarction. Exp Ther Med 2016; 12 (05) 3282-3286
98 Kao A-P, Wang K-H, Chang C-C. , et al. Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril 2011; 95 (04) 1308-15.e1
99 Kidd LJ, Stephens AS, Kuliwaba JS, Fazzalari NL, Wu AC, Forwood MR. Temporal pattern of gene expression and histology of stress fracture healing. Bone 2010; 46 (02) 369-378
100 Toksoy A, Müller V, Gillitzer R, Goebeler M. Biphasic expression of stromal cell-derived factor-1 during human wound healing. Br J Dermatol 2007; 157 (06) 1148-1154
101 Tögel F, Isaac J, Hu Z, Weiss K, Westenfelder C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005; 67 (05) 1772-1784
102 Wang Y, Deng Y, Zhou G-Q. SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 2008; 1195: 104-112
103 Imitola J, Raddassi K, Park KI. , et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 2004; 101 (52) 18117-18122
104 Santamaria X, Massasa EE, Taylor HS. Migration of cells from experimental endometriosis to the uterine endometrium. Endocrinology 2012; 153 (11) 5566-5574